Most people with Sjögren’s syndrome have a normal or near-normal life expectancy. The estimated five-year survival rate after diagnosis is 95%, and the ten-year survival rate is about 90%. While some studies have found a slightly elevated mortality risk compared to the general population, others have found no significant difference at all. The real challenge of living with Sjögren’s is not shortened lifespan but the daily toll it takes on quality of life, and the small but real risk of serious complications that require monitoring.
Life Expectancy Is Close to Normal
The question most people want answered first is whether Sjögren’s syndrome will shorten their life. For the majority, the answer is no. A retrospective study that tracked patients with primary Sjögren’s found the overall mortality rate was nearly identical to the general population, with a standardized mortality ratio of 0.98. A prospective Greek study did find a slightly higher death risk, but other studies failed to replicate that finding. The standardized mortality rate across research generally falls between 0.85 and 1.38, a range that straddles the general population’s baseline.
That said, a subset of patients does face higher risk. People who present at diagnosis with high systemic disease activity, particularly those with constitutional symptoms, lung involvement, or certain immune markers, have roughly double the mortality risk of the general population over seven years. This means prognosis varies considerably depending on how the disease behaves in your body.
What Raises the Risk
Several clinical features at diagnosis are associated with worse outcomes. These include low levels of complement proteins (part of the immune system’s machinery), the presence of cryoglobulins (abnormal proteins that clump in cold temperatures and damage blood vessels), lung involvement, low platelet counts, and liver damage. Male sex and older age at diagnosis also factor in. A large study of over 1,000 patients found that having high activity in at least one disease domain roughly doubled the risk of death, and having more than one abnormal immune marker compounded that risk further.
The most serious long-term complication is lymphoma. People with Sjögren’s have a dramatically elevated risk of developing non-Hodgkin lymphoma compared to the general population, with one study calculating the risk at about 30 times higher. That sounds alarming, but context matters: the baseline rate of non-Hodgkin lymphoma is low, so even a 30-fold increase translates to a small absolute number of cases. In that same study, no patient actually died from lymphoma, and the overall mortality of the group still matched the general population. Still, this risk is the reason regular follow-up matters.
How It Affects Daily Life
Where Sjögren’s syndrome hits hardest is not survival but function. Fatigue and chronic pain affect roughly 70% of patients, and these symptoms cascade into nearly every part of daily life. Research comparing Sjögren’s patients to healthy controls found significant reductions in the ability to concentrate, manage household tasks, care for dependents, and handle basic needs like preparing food or getting to appointments. Patients consistently reported needing more time to complete tasks they once did easily, and many had to develop workarounds or give up activities entirely.
Work is one of the areas most affected. In one study, 55% of Sjögren’s patients were in paid employment compared to 72% of controls. Those who were working reported that joint pain, fatigue, and swelling in the hands and feet directly interfered with their job performance. Many had reduced their hours or lost opportunities for additional work. The gap between what patients felt capable of doing and what they actually could do was a consistent finding across studies.
Beyond Dry Eyes and Dry Mouth
Sjögren’s is often described as a “dryness disease,” but up to 50% of patients develop problems beyond the glands, affecting the skin, lungs, kidneys, joints, and nervous system. The range is wide and varies from person to person.
Lung involvement has one of the broadest prevalence ranges in the literature, reported anywhere from 9% to 75% depending on how it’s measured. It can be as mild as a persistent dry cough or as serious as interstitial lung disease, where inflammation scars the lung tissue. Kidney disorders are rarer, occurring in about 5% of patients. Joint inflammation is common and often one of the first symptoms noticed.
Nerve Damage Is More Common Than Expected
About 15% of people with primary Sjögren’s develop peripheral neuropathy, nerve damage that typically starts in the hands and feet. The most common form, accounting for about 80% of cases, is a length-dependent pattern where the longest nerves are affected first, causing numbness, tingling, and pins-and-needles sensations in the extremities. Pain from neuropathy can be severe enough to limit mobility.
A second pattern, sensory neuronopathy, accounts for about 20% of nerve-related cases. Its hallmark is impaired balance from loss of proprioception, the body’s sense of where its limbs are in space. Carpal tunnel syndrome affects roughly 13% of Sjögren’s patients, and about 4% develop trigeminal neuropathy, which causes numbness or pain in the face. In more severe cases, people experience muscle weakness, cramping, and muscle wasting. Neurological symptoms sometimes appear before the classic dryness, which can delay diagnosis.
Dental Health Requires Extra Attention
Severe dry mouth accelerates tooth decay in a pattern that’s distinct from ordinary cavities. Sjögren’s-related decay tends to hit areas of the teeth that are normally resistant, like the smooth surfaces and the base of the tooth near the gumline. A meta-analysis found that Sjögren’s patients had significantly more decayed, missing, and filled tooth surfaces than controls. Genetic analysis has confirmed that the relationship between Sjögren’s and dental caries is causal, not just coincidental. Proactive dental care, including more frequent cleanings and fluoride treatments, is one of the most practical things you can do to protect long-term oral health.
Pregnancy With Sjögren’s
Women with Sjögren’s who carry certain antibodies (anti-SSA/Ro or anti-SSB/La, which are present in most patients) face a small risk of their baby developing congenital heart block, a condition where the electrical signals controlling the baby’s heartbeat are disrupted. This occurs in about 0.5% of pregnancies in antibody-positive women, and the risk increases slightly with each subsequent pregnancy. It’s uncommon, but serious enough that pregnancies in women with Sjögren’s are typically monitored more closely with fetal heart rate checks during the second trimester, when the risk is highest.
Getting to a Diagnosis Takes Time
One factor that shapes prognosis is how quickly the disease is identified. On average, it takes three years from when symptoms first appear to reach a confirmed diagnosis. That delay matters because untreated inflammation can cause cumulative damage to glands, nerves, and organs. The lag often happens because early symptoms like dry eyes, fatigue, and joint pain overlap with dozens of other conditions and don’t immediately point to a single diagnosis. People who are diagnosed earlier and begin managing the disease sooner tend to preserve more gland function and catch complications before they progress.